Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome - Trial NCT06305195
Access comprehensive clinical trial information for NCT06305195 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 155 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Alexandria University
Timeline & Enrollment
N/A
Aug 23, 2023
Oct 21, 2026
Primary Outcome
Beat-to-beat Heart rate variability,body mass index,Valsalva ratio,Stand 30:15 ratio,deep breath test interpretation
Summary
The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of
 metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic
 individuals.
 
 Heart rate variability will be compared for some antidiabetic drugs used in different stages
 of metabolic diseases and correlated to different metabolic and inflammatory mediators.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06305195
Non-Device Trial